Dynavax Technologies Corporation (DVAX)

Liquidity ratios

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Current ratio 10.80 13.23 14.18 15.20 13.81 15.40 17.78 9.07 4.56 3.82 2.77 2.02 1.09 1.61 2.85 3.91 2.95 4.35 4.99 6.63
Quick ratio 9.08 10.91 11.83 12.92 11.94 13.28 15.19 7.12 4.16 2.40 1.50 1.08 0.98 0.78 1.69 2.13 2.13 2.66 3.77 4.42
Cash ratio 9.08 10.91 11.83 12.92 11.94 13.28 15.19 7.12 4.16 2.40 1.50 1.08 0.98 0.78 1.69 2.13 2.13 2.66 3.77 4.42

Dynavax Technologies Corporation's liquidity ratios have shown fluctuating trends over the years. The current ratio, which measures the company's ability to pay its short-term obligations with its current assets, has generally been above 1, indicating a healthy liquidity position. However, the ratio has experienced significant variations, ranging from a high of 17.78 in June 2023 to a low of 1.09 in December 2021.

The quick ratio, a more stringent measure of liquidity that excludes inventory from current assets, follows a similar pattern of fluctuation. The quick ratio has also exhibited volatility, with a high of 15.19 in June 2023 and a low of 0.78 in September 2021. Despite these fluctuations, the quick ratio has generally shown the company's ability to meet its short-term obligations without relying on inventory.

The cash ratio, which is the most stringent liquidity ratio as it only considers cash and cash equivalents, mirrors the trends seen in the current and quick ratios. The ratio has ranged from a low of 0.78 in September 2021 to a high of 15.19 in June 2023, indicating a wide variation in the company's ability to cover its short-term liabilities with cash holdings alone.

Overall, while Dynavax Technologies Corporation's liquidity ratios demonstrate some level of stability in meeting short-term obligations over time, the fluctuations in these ratios suggest the company's liquidity position may have been impacted by changing business conditions and financial management practices. Monitoring these ratios regularly is essential to ensure the company's continued ability to meet its short-term obligations.

Additional liquidity measure

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash conversion cycle days 517.13 509.27 508.12 485.97 387.72 151.60 115.98 88.89 82.77 144.78 104.89 152.71 128.98 237.06 663.48 741.63 1,671.21 1,477.65 1,188.88 879.21

The cash conversion cycle of Dynavax Technologies Corporation has shown fluctuations over the years.

The company had a prolonged cash conversion cycle in the earlier periods, peaking at 1,671.21 days on December 31, 2020. This indicates that the company was taking a significant amount of time to convert its investments in inventory and other resources into cash inflows from sales.

However, there has been a significant improvement in the cash conversion cycle since then. By December 31, 2021, the cycle had reduced to just 128.98 days, indicating a more efficient management of working capital.

Subsequently, the cycle remained relatively low, with a slight uptick in the later periods. As of December 31, 2024, the cash conversion cycle stood at 517.13 days, which is still an improvement compared to the earlier years.

Overall, the trend suggests that Dynavax Technologies Corporation has been able to better manage its inventory, receivables, and payables, leading to a more efficient conversion of resources into cash.